low-dose radiotherapy
Showing 1 - 25 of >10,000
Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose
Not yet recruiting
- Metastatic Extracranial Malignant Solid Neoplasm
- +3 more
- Intestinal Low Dose Radiotherapy-1Gy
- +3 more
-
Shantou, Guangdong, ChinaCancer Hospital, Shantou University Medical College
Oct 7, 2023
Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)
Recruiting
- Colorectal Liver Metastases
- Radiation: High- and Low-dose radiotherapy
- PD-1 Inhibitors
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Sep 13, 2023
NSCLC Trial (KB-GDT-01)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- KB-GDT-01
- (no location specified)
Sep 29, 2023
Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)
Recruiting
- Cancer Patients
- Low-dose radiotherapy combined with conventional fractionated radiotherapy
-
Jinan, In Shandong Province, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023
Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)
Recruiting
- Microsatellite Stable Metastatic Colorectal Cancer
- Regorafenib
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 19, 2023
Metastatic Cancer Trial in Nanchang (High- and Low-dose radiotherapy)
Recruiting
- Metastatic Cancer
- High- and Low-dose radiotherapy
-
Nanchang, Jiangxi, China
- +1 more
Mar 6, 2023
Arthrosis, Osteoarthritis Trial (low dose radiotherapy (0.5 Gy), mock radiation treatment, low dose radiotherapy (1.0 Gy))
Not yet recruiting
- Arthrosis
- Osteoarthritis
- low dose radiotherapy (0.5 Gy)
- +2 more
- (no location specified)
May 31, 2023
Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)
Recruiting
- Pancreatic Cancer
- LDR
- +2 more
-
Modena, MO, ItalyAzienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022
NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body
Not yet recruiting
- NSCLC
- +3 more
- Low Dose Radiotherapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Nov 11, 2022
Indolent Lymphoma, Low-dose Radiotherapy Trial in Beijing (Low-dose radiotherapy)
Recruiting
- Indolent Lymphoma
- Low-dose Radiotherapy
- Low-dose radiotherapy
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Sep 13, 2022
Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)
Recruiting
- Neoplasms
- Secondary Malignant Neoplasm
- SBRT + LDRT
-
Seoul, Korea, Republic of
- +1 more
Feb 16, 2023
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)
Not yet recruiting
- Neoplasms
- Secondary Malignant Neoplasm
- SBRT + LDRT
- SBRT alone
- (no location specified)
Nov 15, 2022
Non Hodgkin Lymphoma Trial in Philadelphia (Pembrolizumab)
Recruiting
- Non Hodgkin Lymphoma
-
Philadelphia, PennsylvaniaAbamson Cancer Center of the University of Pennsylvania
Jan 9, 2023
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Covid19 Trial in Preston (Low dose Radiotherapy)
Completed
- Covid19
- Low dose Radiotherapy
-
Preston, United KingdomLancashire Teaching Hospitals NHS
Nov 9, 2022
Locally Advanced Nasopharyngeal Carcinoma Trial in Sichuan (low-dose radiotherapy)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- low-dose radiotherapy
-
Sichuan, Sichuan, ChinaLow-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Co
Aug 16, 2022
Cancer Patients Trial in Jinan (At the same time, the original regimen of immunomaintenance therapy was continued, according to
Recruiting
- Cancer Patients
- At the same time, the original regimen of immunomaintenance therapy was continued, according to the frequency of the original immunization regimen once every 3 weeks until progress.
-
Jinan, In Shandong Province, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Sep 16, 2022
Objective Response Rate Trial in Wuhan (GM-CSF)
Recruiting
- Objective Response Rate
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Feb 25, 2023
Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- serplulimab
- +4 more
-
Shantou, Guangdong, China
- +6 more
Mar 1, 2023
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Neoadjuvant Treatment
- Tislelizumab
- Low-dose radiotherapy
-
Zhuhai, Guangdong, ChinaFifth Affilliated Hospital of Sun Yat-sen University
Apr 22, 2022
Hodgkin Lymphoma Trial in Philadelphia (Nivolumab)
Terminated
- Hodgkin Lymphoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
May 20, 2022
Nasopharyngeal Carcinoma Trial (low-dose radiotherapy)
Not yet recruiting
- Nasopharyngeal Carcinoma
- low-dose radiotherapy
- (no location specified)
Mar 22, 2022
Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Carcinoma, Small Cell Lung
- Atezolizumab
- +4 more
-
Beijing City, China
- +7 more
Nov 24, 2022
Glioma Trial in Aviano (Pulsed low dose-rate radiotherapy (pLDRT))
Recruiting
- Glioma
- Pulsed low dose-rate radiotherapy (pLDRT)
-
Aviano, Pordenone, ItalyIRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Sep 20, 2023